Results
|
16621.
|
|
|
16622.
|
|
|
16623.
|
|
|
16624.
|
|
|
16625.
|
|
|
16626.
|
|
|
16627.
|
|
|
16628.
|
|
|
16629.
|
|
|
16630.
|
|
|
16631.
|
|
|
16632.
|
|
|
16633.
|
|
|
16634.
|
|
|
16635.
|
|
|
16636.
|
|
|
16637.
|
|
|
16638.
|
|
|
16639.
|
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group. [electronic resource] by
- Gerhartz, H H
- Marcus, R
- Delmer, A
- Zwierzina, H
- de Witte, T
- Jacobs, A
- Visiani, G
- Fiere, D
- Sonneveld, P
- Labar, B
Producer: 19930311
In:
Infection vol. 20 Suppl 2
Availability: No items available.
|
|
16640.
|
|